Friday Pop Quiz 1/31/2025
Which of the following is not true of this condition?
A. Associated with twin gestation
B. Associated with primigravidas
C. Associated with premature labor
D. Associated with maternal obesity
E. Associated with third trimester of pregnancy
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…
Which of the following is not true of this condition?
A. Associated with twin gestation
B. Associated with primigravidas
C. Associated with premature labor
D. Associated with maternal obesity
E. Associated with third trimester of pregnancy
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Pigmentary distress impacts people of all skin types, according to Dr. Gilly Munavalli, associate clinical professor of dermatology at Wake Forest University School of Medicine. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Munavalli shares how to use lasers and energy-based devices to treat pigmentary disorders. Find out what Dr. Munaval … 
In dermatology, providing safe and effective cosmetic treatments for patients with skin of color requires a deep understanding of their unique needs and challenges. We are fortunate to have experts like Dr. Cheryl Burgess, founder of the Center for Dermatology and Dermatologic Surgery, who has dedicated her career to advancing cosmetic dermatology for diverse populations. In her compelling and inf … 
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patient with vitiligo, is thought to be decreased. This report presents a case of melanoma developing on a non-sun-exposed site in a patient with skin of color and untreated vitiligo. It emphasizes the need … 
In 2022 the FDA approved a medication for the treatment of the condition dipicted in the image. It inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…